As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...

What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...

In a report released today, Luke Sergott from Barclays maintained a Buy rating on 10x Genomics (TXG – Research Report), with a price target of ...

EDT Cathie Wood’s ARK Investment buys 191.5K shares of 10x Genomics (TXG) todayStay Ahead of the Market: Discover outperforming stocks ...

Life Science Company 10x Genomics Struggles With Profitability ... including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Stifel Nicolaus lowered their target price on shares of 10x Genomics from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Citigroup dropped ...

Founded in 2012, 10x Genomics (NASDAQ:TXG ... over the past year and YTD have also been underwhelming, with the stock down -70% and -27% respectively. I initiated my coverage on TXG with a ...

The institutional investor owned 290,031 shares of the company’s stock after selling 45,337 shares during the quarter. Bank of New York Mellon Corp’s holdings in 10x Genomics were worth $ ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...